Publicaciones en las que colabora con José Tuñón Fernández (11)

2021

  1. Mcp-1 predicts recurrent cardiovascular events in patients with persistent inflammation

    Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-13

2020

  1. Correlation between myocardial strain and adverse remodeling in a non-diabetic model of heart failure following empagliflozin therapy

    Expert Review of Cardiovascular Therapy, Vol. 18, Núm. 9, pp. 635-642

2018

  1. Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: Role of GLP-1 isoforms in Glut4 receptor trafficking

    Cardiovascular Diabetology, Vol. 17, Núm. 1

2015

  1. Targeting metabolic disturbance in the diabetic heart

    Cardiovascular Diabetology, Vol. 14, Núm. 1

  2. Updating experimental models of diabetic cardiomyopathy

    Journal of Diabetes Research, Vol. 2015

2013

  1. Alteration of energy substrates and ROS production in diabetic cardiomyopathy

    Mediators of Inflammation, Vol. 2013

  2. Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes

    Cardiovascular Diabetology, Vol. 12, Núm. 1

  3. Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms

    PLoS ONE, Vol. 8, Núm. 10

2012

  1. Proteome changes in the myocardium of experimental chronic diabetes and hypertension. Role of PPARα in the associated hypertrophy

    Journal of Proteomics, Vol. 75, Núm. 6, pp. 1816-1829

2011

  1. Potential role of nuclear factor κb in diabetic cardiomyopathy

    Mediators of Inflammation, Vol. 2011

2009

  1. Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 297, Núm. 6